2-(1H-pyrazol-1-yl)ethan-1-amine dihydrobromide, 95.0%, 1g

3-Aminocyclopentanecarboxylic acid hydrochloride, 95.0%, 10g

2-(8-Chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

Cyclotrimethylenedimethylsilane, 5g

4-[(4-fluorobenzyl)amino]benzoic acid, 95.0%, 1g

4-Chloro-5-nitroquinoline, 95.0%, 100mg

5-Hydroxyisophthalamide, 95.0%, 5g

(R)-2-Aminobut-3-enoic acid hydrochloride, 95%, 100mg

GC-Kapillarsäule ROTI®Cap-5 MS, unpolar, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,35 µm, 1 Stück

[S(R)]-N-[(R)-[4-(1,1-Dimethylethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-2-methyl-2-propanesulfinamide, 95%, 50mg

(2-chlorophenyl)[2-(methoxymethoxy)phenyl]methanone, 95.0%, 5g

10-Methyl-10H-phenothiazine-3-carbaldehyde, 97%, 50mg

5,7-Dibromo-1-benzofuran-2-carboxylic acid, 97%, 250mg